Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-23

Clinical Trial Update: Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacokinetics, relative bioavailability, and safety of Xaracoll implant in hernioplasty; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XaraColl (bupivacaine implant)

Snippet

Sponsor: Innocoll | Conditions: Hernioplasty | Phase 2 | Status: COMPLETED | Results posted: 2018-08-23